Back

Age-dependent detection of Atrial Fibrillation with implantable cardiac monitors in patients with cryptogenic stroke

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation and high-rate episodes: stroke prediction and prevention Diagnostic Methods ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tobias Uhe

University of Leipzig, Leipzig (Germany)

7 More presentations in this session

Presentation thumbnail
Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study
Doctor M. Lehto (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Trends in newly diagnosed atrial fibrillation and oral anticoagulant use after cardiac surgery: a population-based analysis from Ontario, Canada
Mr J. Lee (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Impact of bleeding events on mortality in patients with atrial fibrillation and silent left atrial thrombi: insight from the LAT trial
Doctor M. Okada (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Dynamic change in anticoagulation pattern at age 65 years in patients with atrial fibrillation and prior low thromboembolic risk.
Mr A. Gonzalez Garcia (Vigo, ES)
Abstract Slides Video
Presentation thumbnail
A multiple cut-off diagnostic meta-analysis to identify the atrial high-rate episodes threshold that better relates to thromboembolic events
Doctor A. Ballatore (Turin, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation and high-rate episodes: stroke prediction and prevention

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources